Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study
CLINICAL GENITOURINARY CANCER（2024）
关键词
Immunotherapy,Tyrosine kinase inhibitor,Non clear cell renal cell carcinoma,Safety,Efficacy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要